Search
Hong Kong Stocks Update: Harbour BioMed Rockets 9% to New High, Secures Fresh Investment from Leading Sovereign Fund
3 week ago /
Read about 0 minute
Author：小编
Shares of Harbour BioMed-B soared 9% intraday, achieving a new record high. The company recently announced its interim results, showcasing a year-on-year profit growth exceeding 50 times. Furthermore, the Government of Singapore Investment Corporation (GIC) augmented its stake by acquiring an additional 45.022 million shares worth approximately HK$511 million. Notably, AstraZeneca also joined as a strategic shareholder in March.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
